RLX Financial Statements From 2010 to 2024
| 3CM Stock | EUR 1.85 0.05 2.78% |
Check RLX TECH financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RLX TECH's main balance sheet or income statement drivers, such as , as well as many indicators such as . RLX financial statements analysis is a perfect complement when working with RLX TECH Valuation or Volatility modules.
RLX |
RLX TECH SPADR1 Company Shares Outstanding Analysis
RLX TECH's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current RLX TECH Shares Outstanding | 1.55 B |
Most of RLX TECH's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RLX TECH SPADR1 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, RLX TECH SPADR1 has 1.55 B of shares currently outstending. This is much higher than that of the Technology sector and significantly higher than that of the Health Information Services industry. The shares outstanding for all Germany stocks is 170.7% lower than that of the firm.
RLX TECH SPADR1 Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RLX TECH's current stock value. Our valuation model uses many indicators to compare RLX TECH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RLX TECH competition to find correlations between indicators driving RLX TECH's intrinsic value. More Info.RLX TECH SPADR1 is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for RLX TECH SPADR1 is roughly 1.89 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RLX TECH's earnings, one of the primary drivers of an investment's value.About RLX TECH Financial Statements
RLX TECH stakeholders use historical fundamental indicators, such as RLX TECH's revenue or net income, to determine how well the company is positioned to perform in the future. Although RLX TECH investors may analyze each financial statement separately, they are all interrelated. For example, changes in RLX TECH's assets and liabilities are reflected in the revenues and expenses on RLX TECH's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in RLX TECH SPADR1. Please read more on our technical analysis and fundamental analysis pages.
Cannvas MedTech Inc. operates as a business technology company within the health sciences sector in the United States and internationally. Cannvas MedTech Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada. CANNVAS MEDTECH is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in RLX Stock
RLX TECH financial ratios help investors to determine whether RLX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RLX with respect to the benefits of owning RLX TECH security.